Spectranetics to Hold 2009 Third Quarter Financial Results Conference Call on October 28

• Press Release
• Source: Spectranetics Corporation
• On 7:00 am EDT, Wednesday October 21, 2009

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC - News) today announced that the Company will release 2009 third quarter financial results prior to market open on Wednesday, October 28, 2009. Company management will host an investment-community conference call beginning at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time) on Wednesday, October 28 to discuss those results and to answer questions.

Related Quotes

Symbol	Price	Change
SPNC	5.86	-0.24

{"s" : "spnc","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Individuals interested in listening to the conference call may do so by dialing (888) 803-8271 for domestic callers, or (706) 634-2467 for international callers, or from the webcast on the investor relations section of the Company’s Web site at www.spectranetics.com. A slide presentation will accompany the webcast.

A 48-hour telephone replay will be available approximately one hour after the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 36171056. The webcast will be available on the Company’s Web site for 14 days following the completion of the call.

About Spectranetics

Spectranetics manufactures and markets the only Excimer Laser System approved in the United States, Canada, Europe and Japan for use in minimally invasive interventional procedures within the cardiovascular system. More than 800 Spectranetics laser systems are used in hospitals worldwide.

The Company’s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com.

COMPANY CONTACTS:
Spectranetics Corporation
Guy Childs, Chief Financial Officer
719-633-8333
or
INVESTOR CONTACTS:
Lippert/Heilshorn & Associates, Inc.
Don Markley or Bruce Voss, 310-691-7100
dmarkley@lhai.com